Shenzhen Kangtai Biological Products Co Ltd operates within the Biological products exc. diagnostic sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Shenzhen Kangtai Biological Products Co Ltd with three other
companies in this sector in China:
Shanghai Raas Blood Products Company Limited
sales of 1.80 billion Chinese Renmimbi [US$258.08 million]
of which 40%
Jinyu Bio-Technology Co Ltd
(1.90 billion Chinese Renmimbi [US$271.29 million]
of which 97%
was Bio-Pharmaecutical), and
Beijing SL Pharmaceutical Co Ltd
(2.17 billion Chinese Renmimbi [US$310.04 million]
of which 99%
was Pharmaceuticals Industry).
During the year ended December of 2018, sales at
Shenzhen Kangtai Biological Products Co Ltd were 2.02 billion Chinese Renmimbi (US$288.35 million).
increase of 73.6%
versus 2017, when the company's sales were 1.16 billion Chinese Renmimbi.
This was the fifth consecutive year of sales increases at Shenzhen Kangtai Biological Products Co Ltd
(and since 2013, sales have increased a total of 706%).
Sales of Biological Products saw an increase
73.8% in 2018, from
1.16 billion Chinese Renmimbi to 2.01 billion Chinese Renmimbi.